Hepatitis C virus-specific cellular immune responses post-liver transplantation

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Liver diseases associated with Hepatitis C, including liver failure and liver cancer, are now the leading indication for liver transplantation globally. However, the virus re-infects the new liver and eventually results in scarring and liver failure. This work aims to understand the role of the immune response to the virus in this liver damage, thus allowing modification of existing treatments and development of new therapies that will lead to improved outcomes for these individuals.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2012

Funding Scheme: NHMRC Project Grants

Funding Amount: $470,233.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Cell mediated immunity | Chronic disease caused by hepatitis C virus infection | Cirrhosis | Hepatitis C | Liver diseases | Liver transplantation | Primary hepatocellular carcinoma | Viral Immunology